NEW YORK--(BUSINESS WIRE)--Omrix Biopharmaceuticals, Inc. (“Omrix”) (NASDAQ: OMRI), a fully-integrated biopharmaceutical company that develops and markets biosurgical and immunotherapy products, announced today that Nissim Mashiach, President & Chief Operating Officer, is scheduled to give a company presentation at the Rodman & Renshaw Annual Healthcare Conference on Monday, November 10, 2008 at 2:25 p.m. ET at the New York Palace Hotel in New York City.
